Skip to Main Content

Author Details

Lifang Yang
Cancer Research Institute, Central South University
1998
72
28
PMIDPaper TitleJournal TitlePublished Year
36156329UBE2T promotes glioblastoma malignancy through ubiquitination-mediated degradation of RPL6.Cancer Sci2023
37023940HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma.Cancer Lett2023
37046819Non-Coding RNAs Derived from Extracellular Vesicles Promote Pre-Metastatic Niche Formation and Tumor Distant Metastasis.Cancers (Basel)2023
36882523E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression.Oncogene2023
35119778Optimization of small extracellular vesicle isolation from expressed prostatic secretions in urine for in-depth proteomic analysis.J Extracell Vesicles2022
35411000CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma.Cell Death Dis2022
35565418Extracellular Vesicles in the Progression and Therapeutic Resistance of Nasopharyngeal Carcinoma.Cancers (Basel)2022
36381313MDK induces temozolomide resistance in glioblastoma by promoting cancer stem-like properties.Am J Cancer Res2022
35314213Oncogenic viral infection and amino acid metabolism in cancer progression: Molecular insights and clinical implications.Biochim Biophys Acta Rev Cancer2022
33795637EBV-LMP1 promotes radioresistance by inducing protective autophagy through BNIP3 in nasopharyngeal carcinoma.Cell Death Dis2021
32160975Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling.Cancer Lett2020
31904479VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling.Cancer Lett2020
31930596Epstein-Barr virus-encoded latent membrane protein 1 promotes extracellular vesicle secretion through syndecan-2 and synaptotagmin-like-4 in nasopharyngeal carcinoma cells.Cancer Sci2020
31859574A potential new role of ATM inhibitor in radiotherapy: suppressing ionizing Radiation-Activated EGFR.Int J Radiat Biol2020
33034957microRNA-196a-5p inhibits testicular germ cell tumor progression via NR6A1/E-cadherin axis.Cancer Med2020
32775002LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance.Am J Cancer Res2020
31436393LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling.Cancer Med2019
29330297Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate.Mol Cancer Res2018
29749553EBVâ¿¿LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma.Oncol Rep2018
27996164Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production.Mol Carcinog2017
28364113[Research progress in vasculogenic mimicry in ⿨multiple tumors].Zhong Nan Da Xue Xue Bao Yi Xue Ban2017
28399876Emerging roles of lipid metabolism in cancer metastasis.Mol Cancer2017
26801987Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis.Chin J Cancer2016
27626695Grifolin inhibits tumor cells adhesion and migration via suppressing interplay between PGC1α and Fra-1 / LSF- MMP2 / CD44 axes.Oncotarget2016
27255972EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma.Cancer Lett2016
27432288microRNA-199a-3p functions as tumor suppressor by regulating glucose metabolism in testicular germ cell tumors.Mol Med Rep2016
25245053microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.J Cancer Res Clin Oncol2015
26516701Grifolin directly targets ERK1/2 to epigenetically suppress cancer cell metastasis.Oncotarget2015
26497208Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer.Oncotarget2015
26282825Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.Expert Rev Mol Med2015
26201446miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.Oncotarget2015
26198942[Quantitative assessment of vasculature with DCE-MRI in nasopharyngeal carcinomas following radiotherapy and its value for efficacy evaluation].Nan Fang Yi Ke Da Xue Xue Bao2015
26172457EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma.Oncotarget2015
26112016The receptor proteins: pivotal roles in selective autophagy.Acta Biochim Biophys Sin (Shanghai)2015
25721089Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway.Cancer Lett2015
25714020EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma.Oncotarget2015
25575821Neoalbaconol induces cell death through necroptosis by regulating RIPK-dependent autocrine TNFα and ROS production.Oncotarget2015
25596717Evaluation of a dansyl-based amino acid DNSBA as an imaging probe for apoptosis detection.Apoptosis2015
24145206Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity.Cancer Biol Ther2014
25407966DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.BMC Cancer2014
25344863Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.Oncotarget2014
24662831Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.Oncogene2014
24306928A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.Cell Oncol (Dordr)2014
24322331Therapeutic evaluation of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme for treating of nasopharyngeal carcinomas.Mol Ther2014
23180656(-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells.Carcinogenesis2013
24306423Antiangiogenic and antitumoral effects mediated by a vascular endothelial growth factor receptor 1 (VEGFR-1)-targeted DNAzyme.Mol Med2013
24052072Neoalbaconol induces energy depletion and multiple cell death in cancer cells by targeting PDK1-PI3-K/Akt signaling pathway.Cell Death Dis2013
24042231EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells.Int J Oncol2013
24205157SPATA12 and its possible role in DNA damage induced by ultraviolet-C.PLoS One2013
23983464Delivery system for DNAzymes using arginine-modified hydroxyapatite nanoparticles for therapeutic application in a nasopharyngeal carcinoma model.Int J Nanomedicine2013
  • 1 - 50 of 72

Recommended Authors

Kejun Tang
Women's Hospital, Zhejiang University
Career Start Year 2018
Number of shared co-authors 0
Gen Li
Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 0
Shuling Ren
Beijing Friendship Hospital, Capital Medical University
Career Start Year 2013
Number of shared co-authors 0
Chao Liu
Xiangya Hospital, Central South University
Career Start Year 2013
Number of shared co-authors 0
Meixiao Zhan
Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year 2013
Number of shared co-authors 0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Shuhua Li
The First Affiliated Hospital, Sun Yat-sen University
Career Start Year 2012
Number of shared co-authors 0
Guo Chen
China Pharmaceutical University
Career Start Year 2009
Number of shared co-authors 0
Zhiyong Wang
Moores Cancer Center, University of California San Diego
Career Start Year 2008
Number of shared co-authors 0
Young K Song
National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Liang Liang
Tangdu Hospital, Fourth Military Medical University
Career Start Year 2006
Number of shared co-authors 0
Fan Zhang
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 1
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Career Start Year 2004
Number of shared co-authors 0
Li Liu
Nanfang Hospital, Southern Medical University
Career Start Year 2003
Number of shared co-authors 0
Hae-Yun Jung
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Career Start Year 2002
Number of shared co-authors 2
Aidong Zhou
Southern Medical University
Career Start Year 2002
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Feng Zhu
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
Na Zhang
Obstetrics and Gynecology Hospital of Fudan University
Career Start Year 1997
Number of shared co-authors 1
Jong Bae Park
Henan-Macquarie University Joint Centre for Biomedical Innovation, Henan University
Career Start Year 1997
Number of shared co-authors 0
Erxi Wu
Livestrong Cancer Institutes, Dell Medical School, The University of Texas at Austin
Career Start Year 1997
Number of shared co-authors 0
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 2
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 1
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 0
Seiji Kondo
Fukuoka University
Career Start Year 1992
Number of shared co-authors 0
Qimin Zhan
Peking University Cancer Hospital
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 0
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 2

Collaborators

Deng Pan
College of Plant Protection, Southwest University
Co-authored papers 5
Oliver J Semmes
Eastern Virginia Medical School
Co-authored papers 4
Julius O Nyalwidhe
Eastern Virginia Medical School
Co-authored papers 3
Richard R Drake
Medical University of South Carolina
Co-authored papers 3
Vitold E Galkin
Eastern Virginia Medical School
Co-authored papers 2
Guo Li
Co-authored papers 1
Xiao-Nan Li
Northwestern University
Co-authored papers 1
Cristina Risi
Eastern Virginia Medical School
Co-authored papers 1
Dean A Troyer
Eastern Virginia Medical School
Co-authored papers 1
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
Vanessa L Correll
Leroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Co-authored papers 1
Brian P Main
Leroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School
Co-authored papers 1
Bin Yan
The University of Hong Kong
Co-authored papers 1
Joseph J Otto
Leroy T. Canoles Jr. Cancer Research Center, Eastern Virginia Medical School
Co-authored papers 1
Release 1.2